Cardiovascular Systems Stock Price To Book
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Cardiovascular Systems fundamentals help investors to digest information that contributes to Cardiovascular Systems' financial success or failures. It also enables traders to predict the movement of Cardiovascular Stock. The fundamental analysis module provides a way to measure Cardiovascular Systems' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cardiovascular Systems stock.
Cardiovascular |
Cardiovascular Systems Company Price To Book Analysis
Cardiovascular Systems' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Cardiovascular Systems Price To Book | 2.43 X |
Most of Cardiovascular Systems' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardiovascular Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
CompetitionBased on the latest financial disclosure, Cardiovascular Systems has a Price To Book of 2.4301 times. This is 90.54% lower than that of the Health Care Equipment & Supplies sector and 57.14% lower than that of the Health Care industry. The price to book for all United States stocks is 74.45% higher than that of the company.
Cardiovascular Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardiovascular Systems' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardiovascular Systems could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics of similar companies.Cardiovascular Systems is currently under evaluation in price to book category among its peers.
Cardiovascular Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X | |||
| Price To Book | 2.43 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 236.22 M | |||
| Gross Profit | 172.78 M | |||
| EBITDA | (29.96 M) | |||
| Net Income | (36.93 M) | |||
| Cash And Equivalents | 159.83 M | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 22.15 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 6.05 X | |||
| Book Value Per Share | 5.70 X | |||
| Cash Flow From Operations | (24.27 M) | |||
| Short Ratio | 2.66 X | |||
| Earnings Per Share | (0.96) X | |||
| Price To Earnings To Growth | 177.27 X | |||
| Target Price | 16.75 | |||
| Number Of Employees | 725 | |||
| Beta | 0.74 | |||
| Market Capitalization | 843.96 M | |||
| Total Asset | 322.68 M | |||
| Retained Earnings | (320 M) | |||
| Working Capital | 69.38 M | |||
| Current Asset | 104.88 M | |||
| Current Liabilities | 35.5 M | |||
| Z Score | 22.8 | |||
| Net Asset | 322.68 M |
About Cardiovascular Systems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardiovascular Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiovascular Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiovascular Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |